These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4185867)

  • 1. Alpha-hydroxy fatty acids in hereditary ataxic polyneuritis (Refsum's disease).
    Blass JP; Avign J; Steinberg D
    Biochim Biophys Acta; 1969 Jul; 187(1):36-41. PubMed ID: 4185867
    [No Abstract]   [Full Text] [Related]  

  • 2. Diffuse cerebral sclerosis erroneously reported as Refsum's syndrome.
    Kayden HJ; Reagan TJ; Mize CE; Herndon JH; Steinberg D
    Arch Neurol; 1973 May; 28(5):304-7. PubMed ID: 4121193
    [No Abstract]   [Full Text] [Related]  

  • 3. Refsum's disease: nature of the enzyme defect.
    Steinberg D; Herndon JH; Uhlendorf BW; Mize CE; Avigan J; Milne GW
    Science; 1967 Jun; 156(3783):1740-2. PubMed ID: 4180573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phytol and phytanic acid in 2 cases of hereditary chronic polyneuropathy with uncertain classification: correlations with Refsum's disease].
    Livrea P
    Acta Neurol (Napoli); 1973; 28(1):47-59. PubMed ID: 4122245
    [No Abstract]   [Full Text] [Related]  

  • 5. [Phytol intolerance: Refsum's disease].
    Laudat P
    Biochimie; 1972; 54(5):735-40. PubMed ID: 4120186
    [No Abstract]   [Full Text] [Related]  

  • 6. [At the meeting point of lipidosis and hereditary neuropathies: Refsum's disease].
    Wolf LM; Laudat P
    Ann Biol Clin (Paris); 1969; 27(7):549-58. PubMed ID: 4187679
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of fatty acids on fine structure of cultured neurons. An experimental approach to Refsum's disease.
    Dubois-Dalcq M; Menu R; Buyse M
    J Neuropathol Exp Neurol; 1972 Oct; 31(4):645-67. PubMed ID: 4116916
    [No Abstract]   [Full Text] [Related]  

  • 8. The nature of the metabolic defect in Refsum's disease.
    Steinberg D; Avigan J; Mize CE; Herndon JH; Fales HM; Milne GW
    Pathol Eur; 1968; 3(2):450-8. PubMed ID: 4176998
    [No Abstract]   [Full Text] [Related]  

  • 9. The fatty acid composition of skin and plasma lipids in Refsum's disease.
    Reynolds DJ; Marks R; Davies MG; Dykes PJ
    Clin Chim Acta; 1978 Dec; 90(2):171-7. PubMed ID: 82497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-oxidation as an alternative pathway for the degradation of branched-chain fatty acids in man, and its failure in patients with Refsum's disease.
    Stokke O; Try K; Eldjarn L
    Biochim Biophys Acta; 1967 Oct; 144(2):271-84. PubMed ID: 4168936
    [No Abstract]   [Full Text] [Related]  

  • 11. Absorption of chlorophyll phytol in normal man and in patients with Refsum's disease.
    Baxter JH
    J Lipid Res; 1968 Sep; 9(5):636-41. PubMed ID: 4177872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phytanic acid in Refsum's syndrome.
    Alexander WS
    J Neurol Neurosurg Psychiatry; 1966 Oct; 29(5):412-6. PubMed ID: 4162912
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on the phytol metabolism in lipoidosis heredopathia atactica polyneuritiformis (Refsum's syndrome). The transformation of 3H-phytol into the 3,7,11,15-tetramethylhexadecanoic acid (phytanic acid) of the plasma lipoid fractions].
    Kahlke W; Wagener H; Dieckmann H
    Klin Wochenschr; 1965 Dec; 43(24):1345-7. PubMed ID: 4163289
    [No Abstract]   [Full Text] [Related]  

  • 14. Localization of the oxidative defect in phytanic acid degradation in patients with Refsum's disease.
    Mize CE; Herndon JH; Blass JP; Milne GW; Follansbee C; Laudat P; Steinberg D
    J Clin Invest; 1969 Jun; 48(6):1033-40. PubMed ID: 4181594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different ratios of the LDD and DDD diastereoisomers of phytanic acid in patients with Refsum's disease.
    Eldjarn L; Try K
    Biochim Biophys Acta; 1968 Sep; 164(1):94-100. PubMed ID: 4176022
    [No Abstract]   [Full Text] [Related]  

  • 16. [Refsum's disease].
    Dumas JL
    Presse Med (1893); 1969 Dec; 77(55):2085-90. PubMed ID: 4190509
    [No Abstract]   [Full Text] [Related]  

  • 17. Refsum's syndrome with normal phytate metabolism.
    Ron MA; Pearce J
    Acta Neurol Scand; 1971; 47(5):646-9. PubMed ID: 4110751
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the metabolic error in Refsum's disease.
    Steinberg D; Mize CE; Avigan J; Fales HM; Eldjarn L; Try K; Stokke O; Refsum S
    J Clin Invest; 1967 Mar; 46(3):313-22. PubMed ID: 4164676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refsum's disease: defective oxidation of phytanic acid in tissue cultures derived from homozygotes and heterozygotes.
    Herndon JH; Steinberg D; Uhlendorf BW
    N Engl J Med; 1969 Nov; 281(19):1034-8. PubMed ID: 4188238
    [No Abstract]   [Full Text] [Related]  

  • 20. Refsum's disease: a disorder of lipid metabolism.
    Rake M; Saunders M
    J Neurol Neurosurg Psychiatry; 1966 Oct; 29(5):417-22. PubMed ID: 4162745
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.